Downregulation of miR-133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder

MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma

(2016) Roy Nofech-Mozes et al.   Cancer Medicine

Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥75 years after radical cystectomy for treatment of bladder cancer

(2015) Takahiko Hara et al.   International Journal of Clinical Oncology

MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1

(2014) Xiao-nan Chen et al.   Cancer Cell International

MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer

(2014) Tianzhu Qiu et al.   FEBS LETTERS

Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapy

(2014) Guiming Chen et al.   MEDICAL ONCOLOGY

miR-1 and miR-133b Are Differentially Expressed in Patients with Recurrent Prostate Cancer

(2014) Omer Faruk Karatas et al.   PLoS One

Association of microRNA-126 expression with clinicopathological features and the risk of biochemical recurrence in prostate cancer patients undergoing radical prostatectomy

(2013) Xiaoke Sun et al.   Diagnostic Pathology

Epigenetic Inactivation of KLF4 is Associated with Urothelial Cancer Progression and Early Recurrence

(2013) Heng Li et al.   JOURNAL OF UROLOGY

miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer

(2013) Dacheng Wen et al.   TUMOR BIOLOGY

Oncogenic FGFR3 gene fusions in bladder cancer

(2012) Sarah V. Williams et al.   HUMAN MOLECULAR GENETICS

CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma

(2012) Sandra Rebouissou et al.   JOURNAL OF PATHOLOGY

MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer

(2012) Yunfeng Zhou et al.   Scandinavian Journal of Urology

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center

(2011) Thomas K. Lee et al.   HUMAN PATHOLOGY

miR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo

(2010) Gui Hu et al.   CANCER BIOLOGY & THERAPY

MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death

(2008) R Schickel et al.   ONCOGENE